Suppr超能文献

采用隔日类固醇疗法成功实现肾移植受者的免疫抑制。

Successful immunosuppression of renal allograft recipients with alternate day steroid therapy.

作者信息

Burleson R L, Scruggs B F, Brennan A

出版信息

Clin Nephrol. 1978 Sep;10(3):87-9.

PMID:359210
Abstract

Twenty-five renal transplant recipients have been treated long-term with immunosuppressive therapy with conversion from a daily dose to an every other day dose of steroids in conjunction with daily administration of Imuran. The patients were selected by having stable grafts for 6 to 9 months prior to conversion, not by the presence of steroid-induced complications. Alternate day steroid administration has continued to provide successful immunosuppression in that only of 25 patients (4%) has had any evidence of renewed rejection activity during a treatment interval of 7--95 months, median 22 months and mean 28 months. One graft was lost to an acute rejection reaction that occurred in association with a flu-like syndrome 8 months after the conversion was started. It is concluded that in the patient with documented stability of the graft, every other day steroid administration is a successful immunosuppressive regimen.

摘要

25名肾移植受者长期接受免疫抑制治疗,将类固醇的每日剂量转换为隔日剂量,并每日服用硫唑嘌呤。这些患者是在转换治疗前移植肾功能稳定6至9个月时被挑选出来的,而非因存在类固醇诱导的并发症。隔日给予类固醇持续提供了成功的免疫抑制作用,因为在7至95个月(中位数22个月,平均28个月)的治疗期间,25名患者中只有1名(4%)有再次出现排斥反应活动的任何证据。1例移植肾因在转换治疗开始8个月后发生的与流感样综合征相关的急性排斥反应而丧失。结论是,对于移植肾功能已证实稳定的患者,隔日给予类固醇是一种成功的免疫抑制方案。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验